Navigation Links
MED-EL's new MAESTRO
Date:7/9/2008

Durham, NC (July 9, 2008) MED-EL Corporation announced today new data regarding FineHearingTM technology, available only with the MAESTRO Cochlear Implant System. In addition to hearing in "high definition" with FineHearing, MED-EL's MAESTRO system offers the smallest internal implant and the thinnest, lightest externally-worn speech processor available. The MAESTRO CI system presents surgeons with an option of two internal cochlear implants (SONATATI100 or PULSARCI100) and patients with an option of two speech processors (OPUS 1 or OPUS 2), providing the best possible solution for each individual case. The OPUS Speech Processors offer two new sound coding strategies that make hearing the fine details of sound a reality for people who are profoundly deaf.

"The MAESTRO has created a tremendous capacity for patients to hear, they can filter out certain noises, and they can exist in environments that used to be not really well tolerated by people with cochlear implants. The new system has enabled recipients to hear much better than in the past," said Harold C. Pillsbury, MD, Professor and Chairman of the Department of Otolaryngology, Head and Neck Surgery, University of North Carolina at Chapel Hill.

A clinical investigation which evaluated MED-EL's FineHearing technology demonstrated remarkable improvements in music enjoyment and statistically significant improvements in hearing in noisy environments - two areas of hearing that have been challenging for cochlear implant users.1 A questionnaire of patients who participated in the clinical trial showed that 65% reported improved enjoyment of familiar music, while 59% reported improved enjoyment of music that is unfamiliar. Remarkably, 91% of the subjects reported that, in general, music sounds pleasant with their cochlear implant and 82% reported listening to music every week, if not every day. Also, compared to their current processor, more than half reported improvement in speech understanding while listening in group situations and 60% understood both male and female voices better in everyday noisy environments.1

FineHearing Defines the Finer Details of Sound

Like a telephone, a cochlear implant works by converting sound into complex electrical signals. In an implant, the method used to make this conversion is called a sound coding strategy. During the past two decades, cochlear implant sound coding strategies have only been able to represent one part of a sound, the part known as the "envelope." The other part, called the "fine structure," could not previously be enhanced, due to limitations in technology. Fine structure is comprised of timing cues that provide fine details regarding subtle variations in the pitch of a sound.

With the introduction of FineHearing, MED-EL overcomes the limitations of envelope-based "traditional" coding strategies. MED-EL's new Fine Structure Processing (FSP2) strategy better represents both components of a sound: the envelope and the fine structure. By including the fine structure, the normal hearing process can be represented with greater accuracy than with the envelope alone. In other words, FineHearing can be described as "Hearing in High Definition." The clinical investigation with FineHearing users show clear benefits for speech understanding in background noise. The research also showed that listeners are able to detect smaller differences in pitch, and perceive a wider range of tones. This ability can provide many advantages, including appreciating the richness and complexity of music.1

The Thinnest and Lightest System Means Maximum Comfort in a Minimum Space

MED-EL's latest speech processor, the OPUS 2, is a milestone achievement in engineering, offering unparalleled comfort, battery life, hands-free capability, and remote access to controls. It is the thinnest and lightest processor available today, with a new ergonomic design for maximum comfort and cosmetic appeal. It is the only system with a FineTuner remote control, allowing easy adjustment of settings, without removing the processor from the ear and without interrupting hearing. The processor also includes a standard input jack for connection to FM systems, assistive listening devices even iPod and Bluetooth. Additionally, the SONATATI100 is the smallest titanium cochlear implant on the market, designed to accommodate minimally invasive surgical techniques in less time.

The MAESTRO Cochlear Implant System's state-of-the-art electronics platform also incorporates technology that is well ahead of its time, with the capacity for features not yet available to the cochlear implant users of today. Simple upgrades in external components or computer software can implement these features in the future, allowing recipients to take advantage of MED-EL's intelligent, forward-thinking engineering today and for many years to come.

"The technology used with MAESTRO CI system is a major advancement in that the implant, the part of the system that requires surgery, has capabilities that we have not tapped into yet. We have the ability to update the software, change the coding strategy, and even change electronics in the speech processor such that the implant itself will be able to deliver more information without requiring another surgery," said Dick Collette, President and CEO, MED-EL North America.


'/>"/>

Contact: Rebecca Novak Tibbitt
rebecca@rntcommunications.com
704-341-1544
MED-EL Corporation
Source:Eurekalert  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MED-EL's new MAESTRO
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):
(Date:9/17/2017)... ... 17, 2017 , ... GeneOne Life Science, Inc. announces that ... Safety (KMFDS) for an Investigational New Drug application for a Phase I/IIa study ... The study in Korea represents the second clinical trial for GLS-5300. , ...
(Date:9/14/2017)... ... September 14, 2017 , ... DrugDev ... biotech at the third annual DrugDev Summit, November 7-8, 2017 in Philadelphia, PA. ... most progressive clinical research leaders for best practice case studies, keynote presentations, lively ...
(Date:9/14/2017)... ... September 14, 2017 , ... AxioMed is pleased to ... Dr. Steven Yang completed the procedure on a 35-year-old female patient suffering from ... disc at level L5-S1. The patient failed conservative treatments prior to undergoing surgery. ...
(Date:9/14/2017)... ... September 14, 2017 , ... Cambridge Semantics , the ... that its Anzo Smart Data Lake has been named a KMWorld Trend-Setting ... that help organizations succeed in surpassing their knowledge management goals. KMWorld searches for ...
Breaking Biology Technology: